Richard W. Pascoe is President at Somaxon Pharmaceuticals, Inc. (SOMX). They have made 11 open-market trades across 5 companies since 2009, most recently 2023-03-09.
CIK 0001343266
11 open-market purchases totalling $374K since 2011, never a sale. Across 7 scored buys the stock is up 1.7% at ninety days, and 1.8 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 25% | 25% | 29% |
| Avg Move | -3.2% | +3.7% | +1.7% |
| Alpha | -2.8% | +3.1% | -1.8% |
| Scored | 8 | 8 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZVRA | BUY | 2023-03-09 | 2023-03-13 | $4.20 | $42K | +25.4% | +40.8% | +29.2% |
| KMPH | BUY | 2023-01-13 | 2023-01-13 | $5.44 | $103K | -6.7% | -5.7% | N/A |
| KMPH | BUY | 2022-05-18 | 2022-05-18 | $4.92 | $23K | -3.7% | -10.8% | +14.8% |
| KMPH | BUY | 2021-11-30 | 2021-11-30 | $7.88 | $12K | +4.8% | +11.4% | -26.3% |
| HSTO | BUY | 2021-03-30 | 2021-03-30 | $1.14 | $23K | N/A | N/A | N/A |
| HSTO | BUY | 2020-12-03 | 2020-12-07 | $1.24 | $12K | N/A | N/A | N/A |
| KMPH | BUY | 2020-08-18 | 2020-08-18 | $0.63 | $6K | +0.0% | +0.0% | +0.0% |
| APRI | BUY | 2014-12-22 | 2014-12-22 | $1.02 | $10K | -15.2% | -2.0% | -2.0% |
| APRI | BUY | 2014-10-22 | 2014-10-24 | $1.51 | $18K | -15.2% | -2.0% | -2.0% |
| APRI | BUY | 2013-05-23 | 2013-05-24 | $2.85 | $100K | -15.2% | -2.0% | -2.0% |
| SOMX | SELL · 10b5-1 | 2012-01-03 | 2012-01-04 | $0.48 | $9K | N/A | N/A | N/A |
| SOMX | BUY | 2011-06-10 | 2011-06-13 | $2.25 | $25K | N/A | N/A | N/A |
| SOMX | SELL · 10b5-1 | 2010-12-01 | 2010-12-03 | $2.68 | $37K | N/A | N/A | N/A |
| SOMX | SELL · 10b5-1 | 2010-03-18 | 2010-03-19 | $5.98 | $625K | N/A | N/A | N/A |
| SOMX | SELL · 10b5-1 | 2010-03-01 | 2010-03-03 | $4.01 | $160K | N/A | N/A | N/A |
| SOMX | SELL · 10b5-1 | 2010-02-05 | 2010-02-09 | $3.03 | $188K | N/A | N/A | N/A |
| SOMX | SELL · 10b5-1 | 2009-12-31 | 2010-01-05 | $1.07 | $9K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.